Raymond James Initiates Coverage On Achieve Life Sciences with Strong Buy Rating, Announces Price Target of $20
Portfolio Pulse from Benzinga Newsdesk
Raymond James has initiated coverage on Achieve Life Sciences with a Strong Buy rating and set a price target of $20.
September 27, 2024 | 5:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James has initiated coverage on Achieve Life Sciences with a Strong Buy rating and a price target of $20, indicating a positive outlook for the stock.
The initiation of coverage with a Strong Buy rating and a $20 price target by Raymond James is likely to positively influence investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100